Fig. 2From: Parenteral artemisinins are associated with reduced mortality and neurologic deficits and improved long-term behavioral outcomes in children with severe malariaTreatment with artesunate is associated with reduced systemic inflammation at 1-month follow-up. Box and whisker plots showing the median (interquartile range) and 95% confidence interval of plasma CRP levels measured on enrollment and at 1-month follow-up. The p values on the graph are derived from linear regression models adjusting for child age, sex, and treatment group in the iron studyBack to article page